AI Article Synopsis
- The term pustulotic arthro-osteitis (PAO) was introduced by Sonozaki et al. in 1979, with specific diagnostic criteria established in 1981 that have been widely used for over 40 years.
- Recent efforts have focused on improving patients' quality of life with PAO through early diagnosis and therapy aimed at achieving clinical, structural, and functional remission.
- The article translates the 'Modified PAO Diagnostic Guidance 2022', created by Japan's Ministry of Health and relevant organizations, to aid both Japanese and international rheumatology communities.
Article Abstract
The concept of pustulotic arthro-osteitis (PAO) was first reported by Sonozaki et al. in 1979, with diagnostic criteria (Sonozaki criteria) proposed in 1981. These criteria have served as the gold standard for PAO diagnosis for over 40 years. In recent years, there has been an increasing emphasis on maximizing the quality of life of patients with PAO. This is achieved by striving for clinical remission, structural remission, and functional remission through early diagnosis and appropriate therapeutic intervention from an early stage. This article is an English translation of a summary of the 'Modified PAO Diagnostic Guidance 2022', edited by the Japan Ministry of Health, Labour and Welfare's Research Group on improvement of medical standard and quality of life of patients with spondyloarthritis and related diseases represented by ankylosing spondylitis and the Japan Spondyloarthritis Society. This guidance is intended to be helpful to both Japanese and global communities in rheumatology and spondyloarthritis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/mr/roae003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!